Search

everythinglearnresearchcommunity

for

Search:↓

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Cosmeceuticals may benefit skin health but need more research for efficacy and safety confirmation.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Histone demethylases play a key role in the development of many diseases and may be targets for treatment.

Ayurvedic herbs may reduce side effects and improve effectiveness of cancer treatments.

Histone modification is key in treating chronic inflammatory skin diseases.

Lenalidomide helps hair follicle stem cells turn into melanocytes, which may improve repigmentation in vitiligo.

Platelet-rich plasma may not be very effective for bone healing and hair growth due to a substance it contains that blocks these processes.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Lamivudine might reverse hair graying and needs more research for potential treatments.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.

Using old drugs for new uses can help treat rare immune deficiencies.

No method fully prevents hair loss from chemotherapy, but some methods can reduce it and improve quality of life.

About 22% of cancer patients had skin-related side effects from chemotherapy, but these were usually not severe enough to halt treatment.

The document explains various skin conditions and their treatments.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

The document concludes that rib-sparing techniques in breast reconstruction have limited benefits, sentinel lymph node biopsy is needed for desmoplastic melanoma, certain hair preservation methods improve graft survival, partial turbinectomy effectively reduces nasal obstruction, nipple shields with irrigation may reduce capsular contracture, and thicker malignant melanomas have a higher risk of non-skin cancers.

The document concludes that rib-sparing techniques in breast reconstruction have limited benefits, sentinel lymph node biopsy is needed for desmoplastic melanoma, certain hair preservation methods improve graft survival, partial turbinectomy effectively reduces nasal obstruction, nipple shields with irrigation may reduce capsular contracture, and thicker malignant melanomas have a higher risk of non-skin cancers.

The document lists various dermatology topics, treatments, and diagnostic methods.

Use the least toxic, most specific treatments for skin diseases, considering side effects and individual patient needs.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

Cyclosporin doesn't stop hair loss.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

Targeting a protein that blocks hair growth with microRNAs could lead to new hair loss treatments, but more research is needed.

Drug repurposing speeds up drug development, saves money, and has led to about a third of new drug approvals.

New therapies are being developed that target integrin pathways to treat various diseases.